News
NDTV Profit on MSN58m
Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics BusinessPharmaceutical major Wockhardt Ltd. is going to shift its focus to drug discovery and biologics after exiting the US generics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback